FMR LLC
- SEC CIK
- 0000315066
- Latest filing
- Aug 13, 2026
XLO holding history
Xilio Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XLO overviewAll 13F holders of XLOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −36,558−100.0% | Sold out | Holders |
| Q1 2026 | 36,558 | $307.5K | <0.1% | 00.0% | UnchangedConverted for a 1-for-14 split | Holders |
| Q4 2025 | 511,820 | $327.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 511,820 | $431.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 511,820 | $348.0K | <0.1% | −372,215−42.1% | Reduced | Holders |
| Q1 2025 | 884,035 | $640.4K | <0.1% | −511,818−36.7% | Reduced | Holders |
| Q4 2024 | 1,395,853 | $1.33M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,395,853 | $1.10M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,395,853 | $1.32M | <0.1% | −511,818−26.8% | Reduced | Holders |
| Q1 2024 | 1,907,671 | $2.06M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,907,671 | $1.05M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,907,671 | $4.03M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,907,671 | $5.00M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,907,671 | $6.07M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,907,671 | $5.13M | <0.1% | −312,091−14.1% | Reduced | Holders |
| Q3 2022 | 2,219,762 | $6.46M | <0.1% | −301,571−12.0% | Reduced | Holders |
| Q2 2022 | 2,521,333 | $7.36M | <0.1% | −69,389−2.7% | Reduced | Holders |
| Q1 2022 | 2,590,722 | $18.3M | <0.1% | +20,452+0.8% | Added | Holders |
| Q4 2021 | 2,570,270 | $41.1M | <0.1% | +2,570,270 | New | Holders |